宫颈癌术后盆腔容积调强弧形治疗与固定野调强放疗计划的剂量学研究

doi:10.3760/cma.j.issn.1004-4221.2012.06.018

摘要
图/表
参考文献()
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要

目的研究宫颈癌术后患者应用固定野调强放疗(FF-IMRT)和容积调强弧形治疗(VIMAT)计划剂量学差异。方法选择 13例宫颈癌术后调强放疗患者CT模拟定位并勾画靶区及危及器官,对同一CT图像设计FF-IMRT计划和VIMAT计划,评估计划靶体积(PTV)及危及器官的剂量学参数。两种计划参数比较用配对t检验。结果与FF-IMRT计划相比,VIMAT计划PTV的95%覆盖度增加(t=9.84,P=0.000)、110%覆盖度降低(t=－3.72,P=0.003)、最大剂量(D_max)降低(t=－3.51,P=0.005)、适形指数变差(t=5.93,P=0.000),但PTV105%覆盖度、平均剂量(D_mean)、不均匀指数均相似(t=－0.02、－0.60、1.13,P=0.842、0.560、0.283);膀胱 V₃₀降低约10%(t=－4.99,P=0.000)、D_mean降低1.4 Gy (t=－3.65,P=0.004)、D_max降低1.5 Gy (t=－18.03,P=0.000),直肠 V₄₀降低约10%(t=－2.99,P=0.012),D_mean降低0.6 Gy (t=－2.98,P=0.013)、D_max降低0.8 Gy (t=－4.05,P=0.002),小肠 V₄₀降低最多(10%)(t=－4.74,P=0.001)、D_max降低0.8 Gy (t=－9.45,P=0.000),骨髓 V₅₀降低最多(16%)(t=－4.04,P=0.002)、D_mean降低1.9 Gy (t=－16.21,P=0.000),左、右股骨头 D₅和马尾神经 D_max分别降低1.6、2.7 Gy和1.5 Gy (t=－2.89、－6.22、－4.80,P=0.015、0.000、0.001);机器跳数减少57%(t=－40.54,P=0.000)。结论宫颈癌患者采用VIMAT技术可获得等同于或优FF-IMRT计划的剂量分布,机器数量明显降低,但其疗效还需进一步临床评估。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨波
	庞廷田
	孙显松
	胡克
	邱杰
	张福泉

关键词 ：宫颈肿瘤/放射疗法, 放射疗法,固定野调强, 放射疗法,容积调强, 剂量学

Abstract：

Objective To compare the dosimetry characteristics of volumetric intensity-modulated arc therapy (VIMAT) and fixed field intensity-modulated radiation therapy (FF-IMRT) for cervix cancer. Methods CT images of 13 patients with cervix uteri cancer were transferred into Eclipse planning system. FF-IMRT and VIMAT plans were optimized on an Eclipse treatment planning system using beam data generated for Varian trilogy linear accelerator. Planning target volume (PTV) and organs at risk were evaluated with dose-volume histogram. To appraise the difference between the techniques, the paired t-test was applied.Results Compared with the FF-IMRT plans, PTV95% coverage of VIMAT plan group increased (t=9.84,P=0.000), PTV110% became lower (t=－3.72,P=0.003), D_max decreased (t=－3.51,P=0.005), and CI became worser (t=5.39,P=0.000). PTV105%, D_mean, and HI had no difference (t=－0.02,－0.60,1.13,P=0.842,0.560,0.283). V₃₀ of the bladder was reduced by about 10%(t=－4.99,P=0.000), and D_mean and D_max were 1.4 Gy and 1.5 Gy lower respectively (t=－3.65,－18.03,P=0.004, 0.000);V₄₀ of the rectum was reduced by about 10%(t=－2.99,P=0.012), and D_mean and D_max were reduced by 0.6 Gy, 0.8 Gy respectively (t=－2.98,－4.05,P=0.013,0.002);V₃₀, V₄₀ and V₅₀ of the small intestine were reduced by 16%, 10% and 11%(t=－10.85,－4.74,－8.66,P=0.000, 0.001, 0.000), and D_max was reduced by 0.8 Gy (t=－9.45,P=0.000);V₃₀, V₄₀ and V₅₀ of the bone marrow were reduced by 26%, 19% and 16%(t=－22.10,－10.19,－4.04,P=0.000, 0.000,0.002),and D_mean reduced by 1.9 Gy (t=－16.21,P=0.000);D₅ of the left and right femoral heads were reduced by 1.6 Gy and 2.7 Gy (t=－2.89,－6.22,P=0.015,0.000). D_max of the caudate equine wasreduced by 1.5 Gy (t=－4.80,P=0.001).V₂₀, V₃₀, V₄₀ and V₅₀ of the body were reduced by 18%, 18%, 4% and 3%(t=－7.52,－11.75,－6.26,－6.94,P=0.000, 0.000, 0.000, 0.000). D_mean and D_max of the body decreased by 1.0 Gy and 0.4 Gy (t=－3.72,－3.51,P=0.000, 0.005). Average machine unit (MU) decreased by 57%(t=－40.54,P=0.000).Conclusions cervical cancer Patients with VIMAT technology can get equivalent or superior dose distribution compared with the FF-IMRT technology. And VIMAT technology could reduce MU. But the efficacy needs further clinical evaluation

Key words： Cervix neoplasms/radiotherapy Radiotherapy, fixed field intensity-modulated Radiotherapy, volumetric modulated Dosimetry

收稿日期: 2012-02-29

引用本文:

杨波,庞廷田,孙显松等. 宫颈癌术后盆腔容积调强弧形治疗与固定野调强放疗计划的剂量学研究[J]. 中华放射肿瘤学杂志, 2012, 21(6): 543-545.

YANG Bo,PANG Ting-tian,SUN Xian-song et al. Dosimetric study of volumetric intensity-modulated arc therapy and fixed field intensity-modulated radiotherapy for cervix cancer[J]. Chinese Journal of Radiation Oncology, 2012, 21(6): 543-545.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.issn.1004-4221.2012.06.018 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2012/V21/I6/543

[1] Mundt AJ, Lujan AE, Rotmensch J,et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys,2002,52:1330-1337.
[2] Portelance L, Chao C, Grisby PW, et al. Intensity modulated radiation therapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys,2001,51:261-266.
[3] Verbakel WF, Cuijpers JP, Hoffmans D, et al. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head and neck cancer:a comparative planning and dosimetric study. Int J Radiat Oncol Biol Phys,2009,74:252-259.
[4] Otto K. Volumetric modulated arc therapy:IMRT in a single gantry arc. Med Phys,2008,35:310-317.
[5] Shaffer R, Nichol AM, Vollans E, et al. A comparison of volumetric modulated arc therapy and conventional intensity modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys,2009,76:1177-1184.
[6] Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys,2006,65:1-7.
[7] Yoo S, Wu QJ, Lee WR, et al. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes. Int J Radiat Oncol Biol Phys,2010,76:935-942.
[8] Vanetti E, Clivio A, Nicolini G, et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx hypo-pharynx and larynx:a treatment planning comparison with fixed field IMRT. Radiother Oncol,2009,92:111-117.
[9] Wang JZ, Li XA, D′Souza WD, et al. Impact of prolonged fraction delivery times on tumor control:a note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys,2003,57:543-552.
[10] Moiseenko V, Duzenli C, Durand RE. In vitro study of cell survival following dynamic MLC intensity-modulated radiation therapy dose delivery. Med Phys,2007,34:1514-1520.